Concord Medical Services Holdings Limited CCM NYSE

NYSE • Healthcare • Medical - Care Facilities • CN • USD

SharesGrow Score

22/100

1/6 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Concord Medical Services Holdings Limited (CCM) has a negative trailing P/E of 0.0, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 1.0 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -2,642.71%, forward earnings yield 104.17%.

Criteria proven by this page:

VALUE (0/100, Fail) — negative P/E indicates the company is currently operating at a loss — DCF and P/E-based valuation models cannot produce meaningful results for unprofitable companies (P/E 0.0); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY -2,642.71%).
Forward P/E 1.0 — analysts expect a return to profitability with estimated EPS of $4.18 for FY2027.
Trailing Earnings Yield -2,642.71% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 104.17% as earnings recover.

Overall SharesGrow Score: 22/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score

22/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

✓

FUTURE

100/100

Analyst consensus

→ Forecast

✗

PAST

0/100

→ Income

✗

HEALTH

0/100

Debt-to-Equity & liquidity

→ Health

✗

MOAT

8/100

→ Income

✗

GROWTH

15/100

→ Income

✗

INCOME

10/100

→ Income

Valuation Snapshot — CCM

Valuation Multiples

P/E (TTM)0.0

Forward P/E1.0

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio0.01

EV/EBITDA-16.5

Per Share Data

EPS (TTM)$-662.58

Forward EPS (Est.)$4.18

Book Value / Share$11,994.17

Revenue / Share$1,972.45

FCF / Share$0.00

Yields & Fair Value

Earnings Yield-2,642.71%

Forward Earnings Yield104.17%

Dividend Yield0.00%

Historical Valuation

Year	P/E (TTM)	PEG Ratio	P/B Ratio	P/S Ratio	Dividend Yield
2015	-0.6	0.00	0.03	0.08	2.05%
2016	-0.2	0.00	0.04	0.10	616.65%
2017	-0.1	-0.01	0.03	0.09	-
2018	-0.1	0.00	0.05	0.12	-
2019	0.0	0.00	-0.12	0.08	-
2020	0.0	0.00	-0.01	0.04	-
2021	0.0	0.00	0.00	0.01	-
2022	0.0	0.00	-0.01	0.03	-
2023	0.0	0.00	-0.01	0.02	-
2024	0.0	-0.01	0.00	0.01	-

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2015	$-523.80	$616.49M	$-78.3M	-12.7%
2016	$-1,804.20	$455.04M	$-261.87M	-57.5%
2017	$-1,967.10	$330.98M	$-284.32M	-85.9%
2018	$-2,484.90	$190.9M	$-234.88M	-123%
2019	$-3,818.10	$198.36M	$-307.05M	-154.8%
2020	$-4,600.50	$223.01M	$-309.99M	-139%
2021	$-5,635.50	$485.63M	$-271.43M	-55.9%
2022	$-3,362.70	$472.09M	$-489.66M	-103.7%
2023	$-2,044.20	$537.4M	$-297.66M	-55.4%
2024	$-2,116.80	$383.96M	$-308.24M	-80.3%

Analyst Estimates

Year	EPS (Avg)	EPS Range	Revenue (Avg)	Revenue Range	Analysts
2026	$-18.25	$-18.25 – $-18.25	$440.38M	$440.38M – $440.38M	1
2027	$4.18	$4.18 – $4.18	$244.9M	$244.9M – $244.9M	1
2028	$-7.03	$-7.03 – $-7.03	$184.1M	$184.1M – $184.1M	1
2029	$-15.72	$-15.72 – $-15.72	$241.89M	$241.89M – $241.89M	1
2030	$-10.67	$-10.67 – $-10.67	$291.7M	$291.7M – $291.7M	1